[1] Parsons SJ, Parsons JT. Src family kinases, key regulators of signal transduction. Oncogene, 2004, 23(48): 7906-7909.[2] Shortman K, Wu L. Early T lymphocyte progenitors. Annu Rev Immunol, 1996, 14(1): 29-47.[3] Sebzda E, Mariathasan S, Ohteki T, Jones R, Bachmann MF, Ohashi PS. Selection of the T cell repertoire. Annu Rev Immunol, 1999, 17(1): 829-874.[4] Palacios EH, Weiss A. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene, 2004, 23(48): 7990-8000.[5] Kruisbeek AM, Haks MC, Carleton M, Wiest DL, Michie AM, Zúñiga-Pflücker JC. Branching out to gain control: how the pre-TCR is linked to multiple functions. Immunol Today, 2000, 21(12): 637-644.[6] Wallace VA, Penninger J, Mak TW. CD4, CD8 and tyro-sine kinases in thymic selection. Curr Opin Immu-nol, 1993, 5(2): 235-240.[7] Molina TJ, Perrot JY, Penninger J, Ramos A, Audouin J, Briand P, Mak TW, Diebold J. Differential requirement for p56lck in fetal and adult thymopoiesis. J Immunol, 1998, 160(8): 3828-3834.[8] Molina TJ, Kishihara K, Siderovski DP, van Ewijk W, Narendran A, Timms E, Wakeham A, Paige CJ, Hartmann KU, Veillette A, Davidson D, Mak TW. Profound block in thymocyte development in mice lacking p56lck. Nature, 1992, 357(6374): 161-164.[9] Appleby MW, Gross JA, Cooke MP, Levin SD, Qian X, Perlmutter RM. Defective T cell receptor signaling in mice lacking the thymic isoform of p59fyn. Cell, 1992, 70(5): 751-763.[10] Stein PL, Lee HM, Rich S, Soriano P. pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell, 1992, 70(5): 741-750.[11] Groves T, Smiley P, Cooke MP, Forbush K, Perlmutter RM, Guidos CJ. Fyn can partially substitute for Lck in T lym-phocyte development. Immunity, 1996, 5(5): 417-428.[12] van Oers NSC, Lowin-Kropf B, Finlay D, Connolly K, Weiss A. αβ T cell development is abolished in mice lack-ing both Lck and Fyn protein tyrosine kinases. Immunity, 1996, 5(5): 429-436.[13] Chu DH, van Oers NSC, Malissen M, Harris J, Elder M, Weiss A. Pre-T cell receptor signals are responsible for the down-regulation of Syk protein tyrosine kinase expression. J Immunol, 1999, 163(5): 2610-2620.[14] Levelt CN, Eichmann K. Receptors and signals in early thymic selection. Immunity, 1995, 3(6): 667-672.[15] Zhang WG, Sommers CL, Burshtyn DN, Stebbins CC, DeJarnette JB, Trible RP, Grinberg A, Tsay HC, Jacobs HM, Kessler CM, Long EO, Love PE, Samelson LE. Es-sential role of LAT in T cell development. Immunity, 1999, 10(3): 323-332.[16] Pivniouk V, Tsitsikov E, Swinton P, Rathbun G, Alt FW, Geha RS. Impaired viability and profound block in thy-mocyte development in mice lacking the adaptor protein SLP-76. Cell, 1998, 94(2): 229-238.[17] Abraham KM, Levin SD, Marth JD, Forbush KA, Perlmutter RM. Delayed thymocyte development induced by augmented expression of p56lck. J Exp Med, 1991, 173(6): 1421-1432.[18] Anderson SJ, Abraham KM, Nakayama T, Singer A, Perlmutter RM. Inhibition of T-cell receptor β-chain gene rearrangement by overexpression of the non-receptor protein tyrosine kinase p56lck. EMBO J, 1992, 11(13): 4877-4886.[19] Levin SD, Anderson SJ, Forbush KA, Perlmutter RM. A dominant-negative transgene defines a role for p56lck in thymopoiesis. EMBO J, 1993, 12(4): 1671-1680.[20] Cooke MP, Abraham KM, Forbush KA, Perlmutter RM. Regulation of T cell receptor signaling by a src family protein-tyrosine kinase (p59fyn). Cell, 1991, 65(2): 281-291.[21] Salmond RJ, Filby A, Qureshi I, Caserta S, Zamoyska R. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differ-entiation, and tolerance. Immunol Rev, 2009, 228(1): 9-22.[22] Hernández-Hoyos G, Sohn SJ, Rothenberg EV, Alber-ola-Ila J. Lck activity controls CD4/CD8 T cell lineage commitment. Immunity, 2000, 12(3): 313-322.[23] Legname G, Seddon B, Lovatt M, Tomlinson P, Sarner N, Tolaini M, Williams K, Norton T, Kioussis D, Zamoyska R. Inducible expression of a p56lck transgene reveals a central role for Lck in the differentiation of CD4 SP thymocytes. Immunity, 2000, 12(5): 537-546.[24] Olszowy MW, Leuchtmann PL, Veillette A, Shaw AS. Comparison of p56lck and p59fyn protein expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid cell lines. J Immunol, 1995, 155(9): 4236-4240.[25] Schmedt C, Saijo K, Niidome T, Kühn R, Aizawa S, Ta-rakhovsky A. Csk controls antigen receptor-mediated de-velopment and selection of T-lineage cells. Nature, 1998, 394(6696): 901-904.[26] Schmedt C, Tarakhovsky A. Autonomous maturation of α/β T lineage cells in the absence of COOH-terminal Src kinase (Csk). J Exp Med, 2001, 193(7): 815-826.[27] Lovatt M, Filby A, Parravicini V, Werlen G, Palmer E, Zamoyska R. Lck regulates the threshold of activation in primary T cells, while both Lck and Fyn contribute to the magnitude of the extracellular signal-related kinase re-sponse. Mol Cell Biol, 2006, 26(22): 8655-8665.[28] Zamoyska R, Basson A, Filby A, Legname G, Lovatt M, Seddon B. The influence of the src-family kinases, Lck and Fyn, on T cell differentiation, survival and activation. Immunol Rev, 2003, 191(1): 107-118.[29] Seddon B, Legname G, Tomlinson P, Zamoyska R. Long- term survival but impaired homeostatic proliferation of Naïve T cells in the absence of p56lck. Science, 2000, 290(5489): 127-131.[30] Seddon B, Zamoyska R. TCR and IL-7 receptor signals can operate independently or synergize to promote lym-phopenia-induced expansion of naive T cells. J Immu-nol, 2002, 169(7): 3752-3759.[31] Seddon B, Zamoyska R. TCR signals mediated by Src family kinases are essential for the survival of naive T cells. J Immunol, 2002, 169(6): 2997-3005.[32] Jameson SC. Maintaining the norm: T-cell homeostasis. Nat Rev Immunol, 2002, 2(8): 547-556.[33] Filby A, Seddon B, Kleczkowska J, Salmond R, Tomlinson P, Smida M, Lindquist JA, Schraven B, Zamoyska R. Fyn regulates the duration of TCR engagement needed for commitment to effector function. J Immunol, 2007, 179(7): 4635-4644.[34] Gett AV, Sallusto F, Lanzavecchia A, Geginat J. T cell fitness determined by signal strength. Nat Immu-nol, 2003, 4(4): 355-360.[35] Lanzavecchia A, Sallusto F. Progressive differentiation and selection of the fittest in the immune response. Nat Rev Immunol, 2002, 2(12): 982-987.[36] Kim RK, Yoon CH, Hyun KH, Lee H, An S, Park MJ, Kim MJ, Lee SJ. Role of lymphocyte-specific protein tyrosine kinase (LCK) in the expansion of glioma-initiating cells by fractionated radiation. Biochem Biophys Res Com-mun, 2010, 402(4): 631-636.[37] Scales TM, Derkinderen P, Leung KY, Byers HL, Ward MA, Price C, Bird IN, Perera T, Kellie S, Williamson R, Anderton BH, Reynolds CH. Tyrosine phosphorylation of tau by the SRC family kinases lck and fyn. Mol Neurodegener, 2011, 6(1): 12.[38] Lee KC, Ouwehand I, Giannini AL, Thomas NS, Dibb NJ, Bijlmakers MJ. Lck is a key target of imatinib and dasatinib in T-cell activation. Leukemia, 2010, 24(4): 896-900.[39] Schade AE, Gonzalez-Stawinski G. Immunomodulation via targeted inhibition of antigen receptor signal transduction. Cardiovasc Hematol Disord Drug Targets, 2008, 8(1): 1-6. |